ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 82 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 1.9%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 300,000 | $18,525,000 | 48.35% |
| AJU IB Investment Co., Ltd. | 2,049,331 | $126,546,000 | 47.73% |
| Bain Capital Life Sciences Investors, LLC | 5,615,659 | $346,767,000 | 19.64% |
| Ally Bridge Group (NY) LLC | 903,688 | $55,803,000 | 10.70% |
| Cormorant Asset Management, LP | 6,411,355 | $395,901,000 | 8.82% |
| SECTORAL ASSET MANAGEMENT INC | 1,338,884 | $82,676,000 | 6.27% |
| RA Capital Management | 5,368,451 | $331,502,000 | 5.00% |
| Omega Fund Management, LLC | 847,208 | $52,315,000 | 4.95% |
| Perceptive Advisors | 3,109,224 | $184,693,000 | 2.34% |
| Rock Springs Capital Management LP | 1,694,903 | $104,660,000 | 2.28% |